{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T22:12:02Z","timestamp":1788559922358,"version":"build-2803163510"},"reference-count":61,"publisher":"Cambridge University Press (CUP)","issue":"8","license":[{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"unspecified","delay-in-days":4154,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur. psychiatr."],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"S0924933800259208_abs1\" sec-type=\"other\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Both psychodynamic group therapy (PGT) and clonazepam are used as treatment strategies in reducing symptoms of generalized social anxiety disorder (GSAD). However, many individuals remain symptomatic after treatment with PGT or clonazepam.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0924933800259208_abs2\" sec-type=\"methods\">\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>Fifty-eight adult outpatients with a diagnosis of GSAD according to DSM-IV were randomized to 12 weeks PGT plus clonazepam or clonazepam. The Clinical Global Impression-Improvement (CGI-I) Scale was the primary efficacy measure. Secondary efficacy measures included the Liebowitz Social Anxiety Scale (LSAS) total score, the World Health Organization Instrument to Assess Quality of Life\u2014Brief (WHOQOL-Bref) Scale and the Beck Depression Inventory (BDI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0924933800259208_abs3\" sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      CGI-I data from 57 patients (intent-to-treat population) showed that patients who received PGT plus clonazepam presented significantly greater improvement than those who received clonazepam (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.033). There were no significant differences between the two groups in the secondary efficacy measures.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0924933800259208_abs4\" sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study suggests that the combination of PGT with clonazepam may be a promising strategy for the treatment of GSAD, regarding gains in the global functioning. However the present study failed to detect more specific changes in social anxiety symptomatology between the two groups.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1016\/j.eurpsy.2008.05.004","type":"journal-article","created":{"date-parts":[[2008,9,7]],"date-time":"2008-09-07T18:36:41Z","timestamp":1220812601000},"page":"567-574","source":"Crossref","is-referenced-by-count":42,"title":["A pilot study of clonazepam versus psychodynamic group therapy plus clonazepam in the treatment of generalized social anxiety disorder"],"prefix":"10.1017","volume":"23","author":[{"given":"Daniela Z.","family":"Knijnik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Abrah\u00e3o","family":"Salum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina U.","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarissa","family":"Mombach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00edlia","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atahualpa","family":"Strapasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisele G.","family":"Manfro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udio L.","family":"Eizirik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2020,4,16]]},"reference":[{"key":"S0924933800259208_bib59","doi-asserted-by":"publisher","DOI":"10.1521\/pedi.17.6.510.25357"},{"key":"S0924933800259208_bib58","first-page":"103","article-title":"Clonazepam in social phobia","volume":"46","author":"Versiani","year":"1997","journal-title":"J Bras Psiq"},{"key":"S0924933800259208_bib55","doi-asserted-by":"publisher","DOI":"10.1516\/0020757001599933"},{"key":"S0924933800259208_bib54","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199812000-00002"},{"key":"S0924933800259208_bib53","first-page":"517","article-title":"The concept of unconscious fantasy","volume":"1","author":"Shapiro","year":"1992","journal-title":"J Clin Psychoanal"},{"key":"S0924933800259208_bib51","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp060145"},{"key":"S0924933800259208_bib50","doi-asserted-by":"publisher","DOI":"10.1177\/070674370505000603"},{"key":"S0924933800259208_bib49","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpr.2004.07.007"},{"key":"S0924933800259208_bib48","doi-asserted-by":"publisher","DOI":"10.2174\/157340007780599069"},{"key":"S0924933800259208_bib47","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1987.01800150071009"},{"key":"S0924933800259208_bib46","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-6185(00)00027-X"},{"key":"S0924933800259208_bib43","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2007.164.2.265"},{"key":"S0924933800259208_bib42","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4684-2220-7"},{"key":"S0924933800259208_bib41","doi-asserted-by":"publisher","DOI":"10.1016\/S0193-953X(05)70265-3"},{"key":"S0924933800259208_bib40","doi-asserted-by":"publisher","DOI":"10.1002\/da.20364"},{"key":"S0924933800259208_bib39","doi-asserted-by":"publisher","DOI":"10.1159\/000414022"},{"key":"S0924933800259208_bib60","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0447.108.s417.8.x"},{"key":"S0924933800259208_bib29","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145701002504"},{"key":"S0924933800259208_bib56","volume-title":"Linear mixed models for longitudinal data","author":"Verbeke","year":"2007"},{"key":"S0924933800259208_bib52","first-page":"244","article-title":"Double-blind, placebo-controlled assessment of combined clonazepam with paroxetine compared with paroxetine monotherapy for generalized social anxiety disorder","volume":"65","author":"Seedat","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"S0924933800259208_bib32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200005183422001"},{"key":"S0924933800259208_bib20","doi-asserted-by":"publisher","DOI":"10.1521\/bumc.69.1.1.62267"},{"key":"S0924933800259208_bib25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2850.1997.tb00123.x"},{"key":"S0924933800259208_bib18","doi-asserted-by":"publisher","DOI":"10.1590\/S0034-89102000000200012"},{"key":"S0924933800259208_bib45","doi-asserted-by":"publisher","DOI":"10.1177\/070674378703200215"},{"key":"S0924933800259208_bib17","first-page":"695","article-title":"Psychological and pharmachological treatments of social phobia: a meta-analysis","volume":"23","author":"Fedoroff","year":"2001","journal-title":"Behav Ther"},{"key":"S0924933800259208_bib38","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0213"},{"key":"S0924933800259208_bib61","first-page":"A3","article-title":"Uncharted waters: psychodynamics considerations in the diagnosis and treatment of social phobia","volume":"58","author":"Zerbe","year":"1994","journal-title":"Bull Meninger Clin"},{"key":"S0924933800259208_bib57","first-page":"167","article-title":"Double-blind placebo controlled trial with bromazepam in social phobia","volume":"46","author":"Versiani","year":"1997","journal-title":"J Bras Psiq"},{"key":"S0924933800259208_bib16","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.61.10.1005"},{"key":"S0924933800259208_bib22","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291701004056"},{"key":"S0924933800259208_bib44","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(98)00093-7"},{"key":"S0924933800259208_bib7","doi-asserted-by":"publisher","DOI":"10.1002\/da.10096"},{"key":"S0924933800259208_bib2","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1994"},{"key":"S0924933800259208_bib15","first-page":"20","article-title":"Pharmacotherapy of social anxiety disorder: what does the evidence tell us?","volume":"67","author":"Davidson","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"S0924933800259208_bib24","first-page":"3","article-title":"Psychodynamics of panic disorder and social phobia","volume":"56","author":"Gabbard","year":"1992","journal-title":"Bull Meninger Clin"},{"key":"S0924933800259208_bib14","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199312000-00008"},{"key":"S0924933800259208_bib10","doi-asserted-by":"publisher","DOI":"10.1177\/01454455980223004"},{"key":"S0924933800259208_bib5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.19.2529"},{"key":"S0924933800259208_bib31","first-page":"72","article-title":"A clinical note on social anxiety","volume":"28","author":"Kaufman","year":"1941","journal-title":"Psychoanal Rev"},{"key":"S0924933800259208_bib8","doi-asserted-by":"publisher","DOI":"10.1521\/ijgp.54.4.491.42770"},{"key":"S0924933800259208_bib1","doi-asserted-by":"publisher","DOI":"10.1080\/08039480152693327"},{"key":"S0924933800259208_bib9","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199810000-00004"},{"key":"S0924933800259208_bib6","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1961.01710120031004"},{"key":"S0924933800259208_bib11","first-page":"S62","article-title":"Instrumento para avalia\u00e7\u00e3o de sess\u00f5es de psicoterapia anal\u00edtica","volume":"29","author":"Crestana","year":"2005","journal-title":"Rev Bras Psiq"},{"key":"S0924933800259208_bib23","first-page":"1","volume-title":"The standard edition of the complete psychological works of Sigmund Freud","author":"Freud","year":"1953"},{"key":"S0924933800259208_bib28","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.55.12.1133"},{"key":"S0924933800259208_bib19","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.1.151"},{"key":"S0924933800259208_bib3","doi-asserted-by":"publisher","DOI":"10.1590\/S1516-44462000000300003"},{"key":"S0924933800259208_bib4","doi-asserted-by":"publisher","DOI":"10.1016\/S0005-7967(01)00060-2"},{"key":"S0924933800259208_bib12","first-page":"16","article-title":"Long-term treatment of social phobia with clonazepam","volume":"52","author":"Davidson","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"S0924933800259208_bib13","first-page":"169","article-title":"Pivotal studies of clonazepam in panic disorder","volume":"34","author":"Davidson","year":"1998","journal-title":"Psychopharmacol Bull"},{"key":"S0924933800259208_bib21","first-page":"1111","article-title":"Which psychodynamic therapy for painfully shy patient?","volume":"34","author":"Frances","year":"1983","journal-title":"Hosp Comm Psychiat"},{"key":"S0924933800259208_bib26","volume-title":"Assessment manual for psychopharmacology","author":"Guy","year":"1976"},{"key":"S0924933800259208_bib37","doi-asserted-by":"publisher","DOI":"10.1516\/RFEE-LKPN-B7TF-KPDU"},{"key":"S0924933800259208_bib33","doi-asserted-by":"publisher","DOI":"10.1590\/S1516-44462004000200003"},{"key":"S0924933800259208_bib34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-6163.2002.tb00662.x"},{"key":"S0924933800259208_bib27","doi-asserted-by":"publisher","DOI":"10.1007\/BF01173521"},{"key":"S0924933800259208_bib30","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0408"},{"key":"S0924933800259208_bib35","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psychotherapy.2006.60.3.233"},{"key":"S0924933800259208_bib36","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.61.12.1208"}],"container-title":["European Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924933808015496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924933808015496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0924933800259208","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T05:26:27Z","timestamp":1587101187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0924933800259208\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":61,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0924933800259208"],"URL":"https:\/\/doi.org\/10.1016\/j.eurpsy.2008.05.004","relation":{},"ISSN":["0924-9338","1778-3585"],"issn-type":[{"value":"0924-9338","type":"print"},{"value":"1778-3585","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}